Hirotoshi Echizen
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 18
- Antibiotics Pharmacokinetics and Efficacy 6
- Inflammatory mediators and NSAID effects 6
- Gastroenterology top 2%
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 8
-
- Hormonal Regulation and Hypertension 5
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 18
- Antibiotics Pharmacokinetics and Efficacy 6
- Inflammatory mediators and NSAID effects 6
-
- Cardiac electrophysiology and arrhythmias 7
-
- Drug Transport and Resistance Mechanisms 6
-
- Pharmaceutical Practices and Patient Outcomes 6
- Co-authors
- Harumi TakahashiMichel EichelbaumRyuichi OgawaToshitaka KashimaSosuke KimuraTakashi IshizakiB. VogelgesangG. Wilkinson
- Journals
- Therapeutic Drug Monitoring (10 papers)Clinical Pharmacology & Therapeutics (9 papers)Clinical Pharmacokinetics (8 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Hirotoshi Echizen
94 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 1.2k
- Gastroenterology 311
- Biochemistry 311
- Endocrinology, Diabetes and Metabolism 460
- Pharmacology 387
Countries citing papers authored by Hirotoshi Echizen
This map shows the geographic impact of Hirotoshi Echizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotoshi Echizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotoshi Echizen more than expected).
Fields of papers citing papers by Hirotoshi Echizen
This network shows the impact of papers produced by Hirotoshi Echizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotoshi Echizen. The network helps show where Hirotoshi Echizen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirotoshi Echizen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2019 | 5 | |
| 4 | 2018 | 1 | |
| 5 | 2018 | 11 | |
| 6 | 2018 | 2 | |
| 7 | 2014 | 63 | |
| 8 | 2013 | 34 | |
| 9 | 2012 | 0 | |
| 10 | 2006 | 0 | |
| 11 | 2006 | 3 | |
| 12 | 2001 | 0 | |
| 13 | 1995 | 1 | |
| 14 | 1993 | 10 | |
| 15 | 1993 | 1 | |
| 16 | 1992 | 0 | |
| 17 | 1990 | 17 | |
| 18 | 1988 | 4 | |
| 19 | 1988 | 24 | |
| 20 | 1987 | 20 |
About Hirotoshi Echizen
Hirotoshi Echizen is a scholar working on Pharmacology, Geriatrics and Gerontology, Toxicology, Biochemistry and Gastroenterology, having authored 100 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Cardiac electrophysiology and arrhythmias (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Inflammatory mediators and NSAID effects (6 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Hormonal Regulation and Hypertension (5 papers). The work is most often cited by research in Pharmacology (1.2k citations), Gastroenterology (311 citations), Biochemistry (311 citations), Endocrinology, Diabetes and Metabolism (460 citations) and Pharmacology (387 citations). Hirotoshi Echizen has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Harumi Takahashi, Michel Eichelbaum, Ryuichi Ogawa, Toshitaka Kashima, Sosuke Kimura, Takashi Ishizaki, B. Vogelgesang, G. Wilkinson, Noritsugu Umeda and Curt R. Freed. Their work appears in journals such as Therapeutic Drug Monitoring, Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics, The Journal of Clinical Pharmacology and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.